WO1993021890A1 - Vessel having a plurality of chambers - Google Patents

Vessel having a plurality of chambers Download PDF

Info

Publication number
WO1993021890A1
WO1993021890A1 PCT/JP1993/000558 JP9300558W WO9321890A1 WO 1993021890 A1 WO1993021890 A1 WO 1993021890A1 JP 9300558 W JP9300558 W JP 9300558W WO 9321890 A1 WO9321890 A1 WO 9321890A1
Authority
WO
WIPO (PCT)
Prior art keywords
chamber
container
cover
chambers
weak seal
Prior art date
Application number
PCT/JP1993/000558
Other languages
French (fr)
Japanese (ja)
Inventor
Fujio Inoue
Masamitsu Izumi
Shigetoshi Kashiyama
Original Assignee
Otsuka Pharmaceutical Factory, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26405772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1993021890(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AU42709/93A priority Critical patent/AU654442B2/en
Priority to RU93058573A priority patent/RU2103987C1/en
Priority to CA002112661A priority patent/CA2112661C/en
Priority to DK93911945T priority patent/DK0639364T3/en
Priority to EP93911945A priority patent/EP0639364B1/en
Application filed by Otsuka Pharmaceutical Factory, Inc. filed Critical Otsuka Pharmaceutical Factory, Inc.
Priority to US08/170,215 priority patent/US5423421A/en
Priority to KR1019940700005A priority patent/KR100209830B1/en
Priority to DE69325801T priority patent/DE69325801T2/en
Publication of WO1993021890A1 publication Critical patent/WO1993021890A1/en
Priority to NO934910A priority patent/NO303815B1/en
Priority to FI935972A priority patent/FI107694B/en
Priority to GR990402171T priority patent/GR3031088T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3261Flexible containers having several compartments
    • B65D81/3266Flexible containers having several compartments separated by a common rupturable seal, a clip or other removable fastening device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2024Separating means having peelable seals

Definitions

  • the present invention mainly includes a multi-chamber container used in the medical field, more specifically, a plurality of chambers for accommodating a liquid agent, a powder agent, or a solid agent, and each chamber is partitioned by a partitioning means capable of communicating as appropriate.
  • Flexible double-chamber containers made of plastic.
  • flexible plastic multi-chamber containers having a partitioning means that can be used in the medical field have a tendency to transmit moisture and gas in a very small amount, and therefore have a hygroscopic time-lapse property.
  • a chemically unstable drug such as an antibiotic and a solution such as a saline solution or a dextrose solution or a solution such as a diluent are stored separately in a flexible plastic multi-compartment container.
  • a desiccant absorbs the moisture of the liquid, the moisture-absorbent drug cannot be dried sufficiently, and the liquid concentrates.
  • drugs such as antibiotics that are unstable over time should be stored in a container such as a vial that is impermeable to moisture and gas, and dissolved in physiological saline solution or putu sugar solution that is stored separately when used.
  • a container such as a vial that is impermeable to moisture and gas, and dissolved in physiological saline solution or putu sugar solution that is stored separately when used.
  • a multi-chamber container containing another oxidizable drug for example, an amino acid solution containing tryptophan and a sugar / electrolyte solution (for example, see Japanese Patent Publication No. 63-250550).
  • an amino acid solution containing tryptophan and a sugar / electrolyte solution for example, see Japanese Patent Publication No. 63-250550.
  • a chemical agent sucgar and electrolyte solution
  • a large amount of oxygen scavenger must be used, and a large amount of water and gas barrier outer bags are required, resulting in high costs.
  • An object of the present invention is to provide a flexible plastic double-compartment container which can be used for storing and preserving a liquid, a powder or a solid having hygroscopicity or oxidizability.
  • Another object of the present invention is to provide a multi-chamber container of this type which uses less expensive water and gas barrier film and is therefore inexpensive.
  • Yet another object of the present invention is to provide such a multi-chamber container which does not need to have a glass vial and is therefore easy to dispose of.
  • Still another object of the present invention is to shut off only a chamber containing a liquid, powder, or solid chemical having hygroscopicity or oxidizability from external moisture and oxygen, and enclose a deoxidizer and a desiccant.
  • An object of the present invention is to provide a multi-chamber container capable of preventing oxidation and moisture absorption of the substance without performing the above-mentioned steps.
  • the present invention provides a liquid preparation, a powder preparation, Or a multi-chamber container which is provided with a plurality of chambers for accommodating a solid agent and which is partitioned by a partition means capable of appropriately communicating between the chambers, wherein a flexible plastic container body is provided. At least one of the plurality of chambers formed by the container body is covered by a cover whose peripheral edge is sealed so as to form a closed space around the chamber; The cover is made of a flexible film having a moisture and gas barrier, and the communicable partition means is formed by pressing the chamber so as to increase the internal pressure.
  • a multi-compartment container characterized by being formed of at least one weak seal portion which can be easily peeled off.
  • a chamber without a cover contains a usual substance, for example, a liquid agent, a powder agent or a solid agent having no oxidizability and no Z or hygroscopicity.
  • the above chamber is not covered with a moisture and gas impermeable cover, so it is inferior in moisture and gas barrier properties.
  • the stored contents can be stored for a long time like ordinary plastic containers.
  • the multi-chamber container of the present invention despite being made of a flexible plastic, contains a drug that is hygroscopic and unstable over time, such as an antibiotic, and a liquid such as a dissolving solution or a diluting solution. It can be applied without any hindrance to the intended use.
  • a drug that is hygroscopic and unstable over time such as an antibiotic
  • a liquid such as a dissolving solution or a diluting solution. It can be applied without any hindrance to the intended use.
  • the multi-chamber container of the present invention has a gas-impermeable cover made of an expensive special film
  • the copper is merely provided in a part of the container, so that the cost is high.
  • the use of special films may be small.
  • the increase in packaging costs can be minimized.
  • the cost can be reduced.
  • the plurality of chambers are separated by the weak seal portion, and the weak seal portion is peeled off by the external pressing force to allow the chambers to communicate with each other. And can be mixed while maintaining sterility.
  • the plastic container body and the cover that make up the container are both flexible and easily deformed, they do not need to be separated, and are easier to dispose of than containers made of glass or metal.
  • FIG. 1 is an enlarged vertical sectional view showing a multi-chamber container according to one embodiment of the present invention.
  • FIG. 2 is a front view of the same.
  • FIG. 3 is an enlarged sectional view of a portion A in FIG.
  • FIG. 4 is an enlarged sectional view of a portion B in FIG. 1 ⁇
  • FIG. 5 is an enlarged sectional view of a portion C in FIG.
  • FIG. 6 is an explanatory view showing an example of a preferred method of manufacturing the container of the present invention shown in FIG. 1 in the order of steps.
  • FIG. 7 is a cross-sectional view of a part of a plastic container main body of a double copy container according to another embodiment of the present invention.
  • FIG. 8 is a partial cross-sectional view of a cover of a multi-chamber container according to another embodiment of the present invention.
  • FIG. 9 is a longitudinal sectional view of a multi-chamber container according to still another embodiment of the present invention.
  • FIG. 10 is an enlarged longitudinal sectional view showing another example of the weak seal portion.
  • FIG. 11 is a diagram for storing or transporting the multi-chamber container according to the present invention.
  • FIG. 4 is a perspective view showing a state where the battery pack is sealed in an outer bag.
  • FIG. 12 is a longitudinal sectional view of a multi-chamber container according to still another embodiment of the present invention.
  • FIG. 13 is an explanatory view showing another example of the preferred production method of the container of the present invention in the order of steps.
  • 1 and 2 show an example of the embodiment of the present invention of a two weak seal portion type.
  • a flexible plastic container main body 1 is provided, and the container main body 1 is provided with an opening 2.
  • the plastic container body 1 is obtained by welding two superposed flexible plastic films 3 and 3 at the peripheral edge.
  • the film 3 is not special, and an inexpensive plastic film generally used in the medical field to form a flexible plastic container is used.
  • Fig. 3 shows the outer layer 3a of polyethylene (hereinafter abbreviated as PE), PE and polypropylene. (Hereinafter abbreviated as PP) and an inner layer 3b of the blend are shown.
  • PE polyethylene
  • PP polypropylene
  • two weak seal portions 8a and 8b extending in the lateral direction are formed at the intermediate portion in the height direction by applying a welding means.
  • the weak seal portions 8a and 8b are used to appropriately open the container by using the pressure in the container increased by applying a pressing means or the like, and the welding strength is determined by the welding strength of the peripheral portion of the container body 1. It must be smaller than the wearing strength.
  • the interior of the plastic container body 1 is divided into two upper and lower chambers 1a and 1b by weak seal portions 8a and 8b.
  • the upper container section 1A forming the upper chamber 1a is provided with a force bar 5 so as to cover the periphery thereof, and the lower container section 1B forming the lower chamber 1b has such a force bar. No power par 5 is provided.
  • the force pad 5 is composed of a special film 6 having excellent moisture and gas impermeability.
  • a special film 6 having excellent moisture and gas impermeability.
  • Fig. 5 shows the outer layer 6a.Aluminum processed film such as aluminum film, aluminum vapor-deposited film, etc., which have excellent moisture and gas impermeability, and polyvinylidene chloride and polypropylene ( PP), and a multilayer film in which the inner layer 6b is made of polyethylene.
  • Outer layer 6a, polyvinylidene chloride is polyvinyl alcohol It may be replaced with a silica-deposited film.
  • the cover 5 is composed of two special films 6, 6 arranged so as to cover the periphery of the upper container 1A.
  • the portion not in contact with the upper container 1A is welded between the films 6, 6, and the portion in contact is welded to the outer surface of the upper container 1A.
  • the lower edge welds 6c, 6c of the films 6, 6 are located between the weak seals 8a, 8b as shown in FIG.
  • condition setting depends on the selection of the material of the cover, the welding temperature, and the welding temperature. It is possible by selecting welding conditions such as welding time and welding pressure, but it is quite limited. If two weak seals are used as shown in Fig. 1 and Fig. 4, the lower edge 6c of the cover 5 can be attached to the container body 1 without adversely affecting the welding strength of the weak seals 8a and 8b. Since welding can be performed, there is an advantage that the degree of freedom in selecting the material of the cover and selecting the welding conditions is wider than in the case of a single weak seal portion.
  • the lower edge welded portion 6c of the force pad 5 welded to the space between the two weak seals 8a and 8b is, as is clear from FIG. 4, the respective chambers la and 1b of the container body 1. Is relatively large. As a result, the risk of heat denaturation of the chemicals contained in the chambers 1a and 1b due to heat during the welding operation is alleviated. There are many easily denatured chemicals that have hygroscopicity and easy oxidation, but even those easily denatured without the danger of heat denaturation, the container body at the lower end of the cover 5 Welding to 1 becomes possible. Also, even if an external force is accidentally applied and one weak seal is peeled off, communication between the two chambers can be prevented by the other weak seal.
  • the upper container 1 A with the cover 5 contains a hygroscopic and / or easily oxidizable powder 10, for example, and the lower container 1 B without power 5 contains, for example, a normal liquid 11.
  • the welding temperature during welding of each part is highest at the entire peripheral edge of the plastic container body 1 and the upper edge and both sides of the cover 5, and then at the welding point between the plastic container body 1 and the lower edge of the cover 5.
  • High, weak seals 8a, 8b are the lowest of these. As a result, the welding strength of the weak seal portions 8a and 8b becomes the weakest among the above-mentioned portions.
  • FIG. 6 shows an example of a preferred method of manufacturing the container of the present invention shown in FIGS. 1 and 2, which is described below with reference to (a) to (e) of FIG.
  • Fig. 6 (a) first, two plastic films shown in Fig. 3 are laminated together with the inner layers 3b together, and the three layers are welded at a welding temperature of about 170 to 200 ° C. Make the plastic container body 1 without sealing the periphery. Next, weak sealing portions 8a and 8b are formed in the middle portion of the container body 1 at a welding temperature of about 110 to 130 ° C., and a mouth portion 2 is attached. Then, the container body 1 is divided into an upper container section 1A forming an upper chamber and a lower container section 1B forming a lower chamber.
  • the three sides of the cover 5 are welded to the upper container 1 A using the special film shown in FIG. 5
  • the lower edge 6c to be welded along the weak seals 8a and 8b is located at an intermediate position between these weak seals, and is set so as not to overlap with the weak seals.
  • welding is performed.
  • One side of the cover 5 is opened like the one side of the upper container 1A.
  • powder 10 such as antibiotics was added to the upper container under aseptic conditions.
  • the multi-chamber container of the present invention can be obtained as shown in FIG.
  • the weak seal portion can be formed, for example, by pressing a heated weak seal portion forming mold against the container body by a cylinder device, and the mold is disposed at a predetermined interval from an electric heater. It can be provided with two ridges whose temperature can be adjusted.
  • liquid is stored in container 1A with cover 5 and liquid or powder is stored in container 1B without cover
  • a predetermined substance is accommodated in each of the container parts 1A and 1B, and after filling holes are closed, heat sterilization is performed.
  • the cover 5 may be attached to the upper container 1A, and the side opening of the cover may be sealed.
  • the upper container part 1A is made of a plastic film in which the outer layer is made of PE and the inner layer is made of a blend of PE and PP. It is configured to allow very little moisture and gas (eg, oxygen) to permeate. Since the upper container 1A is provided with the cover 5 made of a special film of moisture and gaseous uniformity, the above-mentioned weak point of the upper container 1A is covered by the function of the cover 5. Thus, in the upper container 1A, a hygroscopic and Z- or oxidizable powder can be stored for a long period of time irrespective of whether it is made of plastic.
  • the cover 5 made of a special film of moisture and gaseous uniformity
  • the weak seal portions 8a and 8b which separate the upper and lower container parts 1A and 1B, are the parts having the lowest welding strength among the welded parts of the respective parts, and therefore press the container part and reduce the pressure in the container. If the pressure is increased, the weak seal portions 8a and 8b are peeled off by this pressure, the two container portions 1A and 1B are in communication with each other, and the liquid material and the powder material contained in the two container portions 1A and 1B are separated. Mix under aseptic conditions to form the desired solution.
  • the powders of the above examples include hygroscopic, easily oxidizable and easily denatured powders such as antibiotics, anticancer agents, steroids, thrombolytic agents, vitamins and the like. And a solution such as a physiological saline solution and a pseudosugar solution.
  • the outer layer 31 is composed of linear low-density polyethylene (hereinafter abbreviated as LLDPE), and the middle layer 33 is composed of LLDPE and low-crystalline (or non-crystalline) ethylene / ⁇ -polyethylene.
  • LLDPE linear low-density polyethylene
  • the middle layer 33 is composed of LLDPE and low-crystalline (or non-crystalline) ethylene / ⁇ -polyethylene.
  • the drug may interact with the low-molecular-weight substance contained in the LLD used in the inner layer of the inner wall over time, producing a reaction product that adversely affects the patient.
  • the LLD used for the inner layer 34 is pretreated at a high temperature and under reduced pressure by, for example, a vent pellet method to remove a low molecular weight substance having about 30 or less carbon atoms to a specific amount or less.
  • the drug and inner layer fill thus, it is possible to suitably prevent the interaction of the system.
  • HDPE high-density polyethylene
  • Special films for the cover include polyvinylidene chloride, polyethylene terephthalate (hereinafter abbreviated as PET), aluminum fluorinolem, ethylene vinyl alcohol copolymer (EVO), It is also possible to use single-layer or multi-layer sheets of the vapor-deposited film. Among them, a silicon vapor-deposited film is transparent and has excellent moisture impermeability and gas impermeability. Therefore, it is preferable to form at least one layer of a sheet.
  • the outer layer 43 was biaxially stretched as shown in FIG.
  • the intermediate layer 44 is silica-deposited PVA
  • the inner layer 45 is low-density polyethylene (LDPE)
  • each layer is a three-layer film 46 fixed with urethane-based adhesive resin.
  • Permeable and gas impermeable barrier films can be mentioned.
  • the cover when welding the plastic container body and the cover, at least the cover must be multilayered in order to improve the welding. It is desirable that the material of the innermost layer of the cover be the same as the material of the outermost layer of the plastic container body. For example, if the outermost layer of the plastic container body is LLDPE, it is desirable to use LLDPE for the innermost layer of the cover.
  • the powder was sealed in the chamber of the container portion covered with the power bar, and the liquid was sealed in the chamber of the container portion not covered with the cover. It is also possible to enclose instead of the agent.
  • cysteine or tributophane are used as the former liquid, respectively.
  • the added amino acid preparation include a readily oxidizable substance such as an amino acid preparation and a vitamin preparation, and the latter liquid preparation includes a sugar-electrolyte solution.
  • the former liquid preparation such as a fat emulsion
  • a liquid oxidizing substance, for the latter liquid agent is a sugar-electrolyte solution or the like.
  • examples of the above-mentioned powders, liquids, and solids include various other nutrients and therapeutic agents to be administered intravenously or enterally (tube or oral).
  • the substance enclosed in the chamber of the container part covered with the cover has photodegradability, use aluminized film on part or all of the cover to shield the inside from light. You may.
  • the aluminum processed film used for the cover may be partly or entirely peelable as needed at the time of use.
  • the above-described embodiment is an example of a two-chamber container enclosing a liquid agent and one kind of powder agent, but can be applied to two or more chambers.
  • Figure 9 shows an example. Inside the cover 5, a container 1A 'having chambers 1a and 1 & 2 for enclosing two kinds of powders (or a powder and a solid) is arranged. Liquid material 11 is stored in container part 1B without a cover. Not only powders and solids but also multiple chambers for liquids can be provided.
  • the air in the space is replaced with the inert gas, so that the effect of preventing oxidation is roughly ensured.
  • the dry gas is sealed, the air in the space is replaced with the dry gas. Since it is replaced, the moisture-proof effect is further ensured.
  • the space between the container body and the cover can be further protected by inert gas or drying.
  • inert gas or drying By sealing gas or the like, high stability over time of the drug can be achieved without adding an oxygen scavenger and a desiccant in the space as in the related art.
  • the number of weak seal portions is not limited to two, but may be two or more, or may be one.
  • the weak seal portion does not necessarily have to be a straight line, and for example, may have a V-shape such that the vicinity of the center of the chamber covered with the cover projects. In this way, you can press on one of the chambers by hand during use When a force is applied, the force for peeling off the weak seal concentrates on the V-shaped portion, so that the medicine can be mixed by peeling the weak seal with a relatively small pressing force.
  • there is a risk of inadvertent peeling during storage or transportation of the multi-chamber container so it is desirable to particularly examine the welding conditions.
  • the weak seal portion is formed by a so-called direct welding method in which the inner surfaces of two sheets constituting the container body are directly welded to each other.
  • a so-called multilayer insert film sandwiching welding method may be used in which the multilayer insert film is welded to form a weakly sealed portion while sandwiching the multilayer insert film.
  • Figure 10 shows an example using a two-layer insert film.
  • ⁇ 3 is a film for forming a container consisting of a single-layer film or a multilayer film
  • 18 is a sheet having a strong thermal adhesion to the innermost layer of the above-mentioned film 3
  • 19 is the opposite side.
  • the film 3 is a single-layer film of PE or PP
  • 18 is the same sheet of PE or PP
  • 19 is a mixed resin of PE and PP.
  • 21a and 21b are weak seal portions.
  • Insert film is weak seal It may be bisected according to the part.
  • the cover 12 may be welded over the weak seal portion of the multilayered ink film, but the condition is that the weak sealing property of the container body is maintained.
  • the cover may also be adhered to the container body 5 with an adhesive or an adhesive.
  • the container be folded in two at the weak seal portions 8a and 8b and sealed in the outer bag 50 as shown in FIG. In this way, by folding in two, unnecessary peeling of the weak seal portion due to heavy pressure due to stacking during storage or external force such as “10 drop” can be prevented.
  • the mouth 'portion 2' is provided in the chamber 1a 'for containing the powdered drug 10 such as an antibiotic, and the chamber 1b' for containing the drug 11 such as a solution is closed. You may make it. 15 If an opening is provided in the chamber that contains the solution such as the solution, there is a risk that in the case of an emergency, only the solution such as the solution is administered first without performing the mixing operation by mistake. However, as described above, by attaching the mouth 2 ′ to a room containing a powder drug such as an antibiotic, there is an advantage that the above danger can be avoided.
  • FIGS. 13 (a) to 13 (j) As shown in FIG. 13 (a), a hole 2a for a mouth portion is formed in a two-layer type plastic film 3 shown in FIG.
  • the periphery of the two stacked films 3 is welded at a welding temperature of about 170 to 2 mm, leaving the filling ports 35 and 36 for chemicals and powders. Seal at 0 ° C to obtain plastic container body 1.
  • the filling port 35 among the filling ports 35 and 36 may be formed in a later step.
  • two weak seal portions 8 a and 8 b which are parallel to each other with an interval portion 39 are provided at an intermediate portion of the container body 1, with a welding temperature of about 110. Formed at ⁇ 130 ° C.
  • the appropriate width of the weak seal part is about 10 mm for the weak seal part 8b, and about 5mm for the weak seal part 8a.
  • the filling port 36 is provided in the lower container part 1B. After filling the liquid material 11 through, both filling ports 35 and 36 are sealed, and high-pressure steam sterilization is performed.
  • Fig. 13 (g) after completion of the sterilization, the outside of the container body 1 is dried, and the filling port 35 is urged under aseptic conditions to refill the filling port 35. Open, and the inside of upper container 1A is dried and cleaned by blowing clean air through b.
  • the powder 10 is filled under aseptic conditions into the upper container 1A through the filling port 35, and after filling, the filling port 35 is sealed.
  • a power bar 5 is provided using the special film 6 shown in FIG. 5 so as to cover the periphery of the upper container 1A.
  • one of the films 6, 6 is transparent and the other is opaque.
  • the welded portions 6b of the films 6, 6 are formed so that the heat does not substantially reach the filled drug 10. It is preferable to leave an interval of about 5 mm between the upper container 1A and the chamber 1a.
  • the width of the welded portion l A t the peripheral especially both side portions of the upper container section 1 A is required to be greater than 5 mm, typically expects the welding width of Fi Lum 6 Is set to about 7 to 10 mm.
  • the lower edge 6c of the film 6 constituting the cover 5 is provided between the two weak seal portions 8a and 8b. It is welded to the position of the gap 9.
  • the welding temperature is about 150 to 170 ° C when using a transparent film 6, and 130 to 15 when using an opaque aluminized film. Welded at 0 ° C.
  • the cover 5 provided on the upper container 1A is initially partially open on one side, and through this opening 40, the cover 5 and the upper container 1 are opened. After injecting an inert gas or a dry gas into the space 7 between A, the opening 40 is sealed, and as shown in FIG. A chamber container is obtained.
  • the optimum temperature range is selected for each welding temperature depending on the material of the film, the setting of the welding strength, and the like, and is not limited to the above-mentioned welding temperature range. is not.

Abstract

A vessel having a plurality of chambers for use mainly in the medical field, wherein the interior of the main body of a flexible plastic vessel is partitioned into a plurality of chambers by use of a partitioning means permitting suitable communication between the chambers, out of respective vessel portions of the main body of the plastic vessel, which constitute the plurality of chambers, at least one vessel portion has no cover and at least another vessel portion has a cover, said cover covering the peripheral surface of said vessel portion through a tightly sealed space portion and being formed of flexible film having moisture-proof and gas barrier properties, so that the easily disposable vessel having the plurality of chambers, which is inexpensive and high in quality and performance can be provided.

Description

明 細 書  Specification
複 室 容 器  Double room container
技 術 分 野  Technical field
本発明は主として医療分野で用いられる複室容器、 よ り詳しく は液剤、 粉末剤も しく は固形剤を収容するため の複数の室を備え、 各室間が適宜連通可能な仕切り手段 により仕切られた可撓性のブラスチッ ク製複室容器に関 する。  The present invention mainly includes a multi-chamber container used in the medical field, more specifically, a plurality of chambers for accommodating a liquid agent, a powder agent, or a solid agent, and each chamber is partitioned by a partitioning means capable of communicating as appropriate. Flexible double-chamber containers made of plastic.
背 技 te  Tricks te
従来より、 医療分野で使用されている連通可能な仕切 り手段を有する可撓性のプラスチッ ク製複室容器は、 極 く微量ながら水分やガスを透過する傾向があるため、 吸 湿性を有する経時的に不安定な抗生物質等の薬剤と生理 食塩液ゃプ ドウ糖液等の溶解液又は希釈液等の液剤を可 撓性のプラスチッ ク製複室容器を用いて分割して保存す る場合には、 複室容器を乾燥剤と共に高価な水分及びガ スバリ アー性の外装袋に入れる必要がある。 ところが、 乾燥剤が液剤の水分を吸収するため、 吸湿性を有する薬 剤の乾燥が充分行えず、 更に液剤の濃縮化が起こるとい う不都合が生じるところから、 吸湿性を有する経時的に 不安定な抗生物質等の薬剤と液剤とを分割して可撓性の プーラスチッ ク製複室容器に入れて保存することは、 従来 行われていなかった。 Conventionally, flexible plastic multi-chamber containers having a partitioning means that can be used in the medical field have a tendency to transmit moisture and gas in a very small amount, and therefore have a hygroscopic time-lapse property. When a chemically unstable drug such as an antibiotic and a solution such as a saline solution or a dextrose solution or a solution such as a diluent are stored separately in a flexible plastic multi-compartment container. For this purpose, it is necessary to put the multi-chamber container together with a desiccant in an expensive moisture and gas barrier outer bag. However, since the desiccant absorbs the moisture of the liquid, the moisture-absorbent drug cannot be dried sufficiently, and the liquid concentrates. Conventionally, it has been difficult to separate a drug such as an antibiotic and a liquid into a flexible plastic double-compartment container and store it. Had not been done.
故に、 経時的に不安定な抗生物質等の薬剤は、 水分及 びガス非透過性のバイアル瓶等の容器に保存し、 使用時 に別に保存されている生理食塩液やプドゥ糖液等の溶解 液又は希釈液と混合溶解又は希釈して患者に投与してい ο  Therefore, drugs such as antibiotics that are unstable over time should be stored in a container such as a vial that is impermeable to moisture and gas, and dissolved in physiological saline solution or putu sugar solution that is stored separately when used. Liquid or diluent mixed with or dissolved and administered to patients ο
しかし、 上記方法では操作が煩雑でしかも操作時に細 菌汚染の危険があるため、 経時的に不安定な抗生物質を 封入したバイアル瓶と溶解液を入れた可撓性のプラスチ ック製容器を穿刺針を介して一体に組合わせた容器が開 発されるようになつてきた (例えば特開平 2— 1 2 7 7 号参照) 。 この容器は、 混合操作を箇便に無菌的に行う ことができるなどの利点を有するが、 廃棄時にはガラス パイアル、 可撓性容器及び連通具を分離するのに大変手 間がかかって、 廃棄処理が困難であり、 従って現在クロ ーズァヅプされている医療用廃棄物の処理の容易性とい う要求を充足できないという問題点があつた。  However, in the above method, the operation is complicated, and there is a risk of bacterial contamination during the operation. Containers that have been combined together via a puncture needle have been developed (for example, see Japanese Patent Application Laid-Open No. 2-12777). This container has the advantage that the mixing operation can be performed aseptically on the stool, but at the time of disposal, it takes a lot of time to separate the glass pial, the flexible container and the communication device, and the disposal process Therefore, there is a problem that the demand for easy disposal of medical waste currently being closed cannot be satisfied.
更に、 易酸化性を有する他の薬剤、 例えばト リプトフ ァンを含むァミノ酸液と糖 ·電解質液とを収容した複室 容器 (例えば特公昭 6 3 - 2 0 5 5 0号参照) の場合は、 経時変化を防止するため、 脱酸素剤と共に高価な水分及 びガスバリァー性の外装袋に入れて保存しなければなら ない。 そして、 この場合脱酸素剤を作用させる必要のな い薬剤 (糖 ·電解質液) も一緒に入れるこ とから空間容 積が大き く なり、 酸素吸収能力の大きい脱酸素剤を使用 するか、 又は多量の脱酸素剤を使用しなければならない と共に、 水分及びガスバリ アー性の外装袋を多量に必要 とするためコス 卜が高く なるという欠点がある。 Furthermore, in the case of a multi-chamber container containing another oxidizable drug, for example, an amino acid solution containing tryptophan and a sugar / electrolyte solution (for example, see Japanese Patent Publication No. 63-250550). Must be stored in expensive water and gas barrier outer bags with oxygen scavengers to prevent aging. Absent. In this case, since a chemical agent (sugar and electrolyte solution) that does not need to act as an oxygen absorber is also added, the space capacity is increased, and an oxygen absorber having a large oxygen absorbing capacity is used, or A large amount of oxygen scavenger must be used, and a large amount of water and gas barrier outer bags are required, resulting in high costs.
発 明 の 開 示  Disclosure of the invention
本発明の 1つの目的は、 吸湿性や易酸化性を有する液 剤、 粉末剤も しく は固形剤の収容保存に適用できる可撓 性を有するプラスチッ ク製複室容器を提供するにある。  An object of the present invention is to provide a flexible plastic double-compartment container which can be used for storing and preserving a liquid, a powder or a solid having hygroscopicity or oxidizability.
本発明の他の 1つの目的は、 高価な水分及びガスバリ ァー性フィ ルムの使用量が少なく従って安価なこの種の 複室容器を提供するにある。  Another object of the present invention is to provide a multi-chamber container of this type which uses less expensive water and gas barrier film and is therefore inexpensive.
本発明の更に他の 1つの目的は、 ガラスバイアルを備 える必要がなく、 従って廃棄が容易なこの種複室容器を 提供するにある。  Yet another object of the present invention is to provide such a multi-chamber container which does not need to have a glass vial and is therefore easy to dispose of.
本発明の更に他の 1つの目的は、 吸湿性又は易酸化性 を有する液体、 粉末又は固形の薬剤を収容した室のみを 外部の水分や酸素から遮断すると共に、 脱酸素剤や乾燥 剤を封入することなく、 前記物質の酸化防止や吸湿防止 を図り得る複室容器を提供することにある。  Still another object of the present invention is to shut off only a chamber containing a liquid, powder, or solid chemical having hygroscopicity or oxidizability from external moisture and oxygen, and enclose a deoxidizer and a desiccant. An object of the present invention is to provide a multi-chamber container capable of preventing oxidation and moisture absorption of the substance without performing the above-mentioned steps.
本発明は、 この目的を達成するために、 液剤、 粉末剤 もしく は固形剤を収容するための複数の室を備えている と共に各室間が適宜連通可能な仕切り手段によつて仕切 られた複室容器であって、 可撓性のプラスチッ ク容器本 体を具備し、 該容器本体により形成された複数の室のう ち、 少なく とも 1つの室は該室の周囲に密閉空間部を形 成するように周縁部をシールされたカバーにより覆われ、 他の室は力パーなしであり、 前記カバーは水分及びガス バリァー性の可撓性フィ ルムから構成されており、 前記 連通可能な仕切り手段は、 内圧を高めるように前記室が 押圧されることにより容易に剥離し得る少なく とも 1本 の弱シール部 より形成されていることを特徴とする複 室容器を提供する。 The present invention provides a liquid preparation, a powder preparation, Or a multi-chamber container which is provided with a plurality of chambers for accommodating a solid agent and which is partitioned by a partition means capable of appropriately communicating between the chambers, wherein a flexible plastic container body is provided. At least one of the plurality of chambers formed by the container body is covered by a cover whose peripheral edge is sealed so as to form a closed space around the chamber; The cover is made of a flexible film having a moisture and gas barrier, and the communicable partition means is formed by pressing the chamber so as to increase the internal pressure. Provided is a multi-compartment container characterized by being formed of at least one weak seal portion which can be easily peeled off.
本発明複室容器においては、 容器の各室の内、 カバー なしの室に、 通常物質、 例えば易酸化性及び Z又は吸湿 性を有しない液剤、 粉末剤もしく は固形剤が収容される。 上記室は水分及びガス非透過性のカバーで覆われていな いので水分及びガスバリァー性に劣るが、 通常物質の収 容であるので、 通常のプラスチック容器と同様に収容物 質を長期保存できる。  In the multi-chamber container of the present invention, in each chamber of the container, a chamber without a cover contains a usual substance, for example, a liquid agent, a powder agent or a solid agent having no oxidizability and no Z or hygroscopicity. The above chamber is not covered with a moisture and gas impermeable cover, so it is inferior in moisture and gas barrier properties. However, since it contains normal substances, the stored contents can be stored for a long time like ordinary plastic containers.
一方カバーで覆われた室に、 特殊物質、 例えば易酸化 性及び/又は吸湿性の液剤、 粉末剤もしく は固形剤が収 容される。 上記室を形成するプラスチッ ク容器本体は極 く僅かながらプラスチッ ク固有の水分及びガス透過性を 有し、 水分及びガスバリアー性に劣る。 しかしながら、 上記室の周囲を覆っているカバーは、 水分及びガス非透 過性の特殊フィ ルムから構成されているので、 プラスチ ッ ク製容器本体の水分及びガスパリァー性不足に拘らず、 上記特殊物質を変質の虞れなしに長期間保持できる。 On the other hand, special substances such as oxidizable and / or hygroscopic liquids, powders or solids are stored in the covered room. The plastic container body that forms the above chamber is extremely It has very little moisture and gas permeability inherent to plastic, and is inferior in moisture and gas barrier properties. However, since the cover covering the periphery of the above chamber is made of a moisture and gas impermeable special film, regardless of the lack of moisture and gas barrier properties of the plastic container body, the special substance Can be maintained for a long time without fear of deterioration.
斯く して本発明複室容器は、 可撓性プラスチッ ク製で あるに拘らず、 吸湿性を有し経時的に不安定な薬剤例え ば抗生物質と、 溶解液や希釈液等の液剤を収容する用途 に支障なく適用できる。  Thus, the multi-chamber container of the present invention, despite being made of a flexible plastic, contains a drug that is hygroscopic and unstable over time, such as an antibiotic, and a liquid such as a dissolving solution or a diluting solution. It can be applied without any hindrance to the intended use.
更に本発明複室容器においては、 高価な特殊フ ィ ルム からなるガス非透過性のカバーを備えているとはいえ、 該カパーは容器の一部に単に備えられているに過ぎない ので高価な特殊フィ ルムの使用量は少なく てよい。 した がつて包装コス トの上昇を、 最少限にとどめるこ とがで きる。 また、 容器本体とカバーとの間に脱酸素剤や乾燥 剤を封入しなく てもよいので、 コス トを軽減するこ とが できる。  Further, although the multi-chamber container of the present invention has a gas-impermeable cover made of an expensive special film, the copper is merely provided in a part of the container, so that the cost is high. The use of special films may be small. Thus, the increase in packaging costs can be minimized. Further, since it is not necessary to enclose an oxygen scavenger or a desiccant between the container body and the cover, the cost can be reduced.
更に本発明複室容器は、 複数の室が弱シール部により 仕切れら、 外部からの押圧力により該弱シール部が剥が れて室相互の連通が可能となるので、 薬剤を外気に触れ させることなく無菌状態を保って混合することができる。 また、 容器を構成するプラスチック容器本体とカバーは いずれも可撓性で変形容易であるので、 分離の必要がな く、 ガラスや金属を使甩した容器に比し廃棄処理が容易 の O Further, in the multi-chamber container of the present invention, the plurality of chambers are separated by the weak seal portion, and the weak seal portion is peeled off by the external pressing force to allow the chambers to communicate with each other. And can be mixed while maintaining sterility. In addition, since the plastic container body and the cover that make up the container are both flexible and easily deformed, they do not need to be separated, and are easier to dispose of than containers made of glass or metal.
図面の簡単な説明  BRIEF DESCRIPTION OF THE FIGURES
図 1は本発明の 1実施例に係る複室容器を示す拡大縦 断面図である。  FIG. 1 is an enlarged vertical sectional view showing a multi-chamber container according to one embodiment of the present invention.
図 2は同正面図である。  FIG. 2 is a front view of the same.
図 3は図 1の A部の拡大断面図である。  FIG. 3 is an enlarged sectional view of a portion A in FIG.
図 4は図 1の B部の拡大断面図である^  FIG. 4 is an enlarged sectional view of a portion B in FIG. 1 ^
図 5は図 1の C部の拡大断面図である。  FIG. 5 is an enlarged sectional view of a portion C in FIG.
図 6は図 1に示された本発明容器の好ましい製造法の 一例を工程順に示す説明図である。  FIG. 6 is an explanatory view showing an example of a preferred method of manufacturing the container of the present invention shown in FIG. 1 in the order of steps.
図 7は本発明の他の実施例に係る複寫容器のプラスチ ック容器本体の一部の断面図である。  FIG. 7 is a cross-sectional view of a part of a plastic container main body of a double copy container according to another embodiment of the present invention.
図 8は本発明の他の実施例に係る複室容器のカバーの 一部の断面図である。  FIG. 8 is a partial cross-sectional view of a cover of a multi-chamber container according to another embodiment of the present invention.
図 9は本発明のさらに他の実施例に係る複室容器の縦 断面図である。  FIG. 9 is a longitudinal sectional view of a multi-chamber container according to still another embodiment of the present invention.
図 1 0は弱シール部の他の例を示す拡大縦断面図であ 図 1 1は本発明に係る複室容器を保存又は輸送のため に外装袋に封入した状態を示す斜視図である。 FIG. 10 is an enlarged longitudinal sectional view showing another example of the weak seal portion. FIG. 11 is a diagram for storing or transporting the multi-chamber container according to the present invention. FIG. 4 is a perspective view showing a state where the battery pack is sealed in an outer bag.
図 1 2は本発明のさ らに他の実施例に係る複室容器の 縦断面図である。  FIG. 12 is a longitudinal sectional view of a multi-chamber container according to still another embodiment of the present invention.
図 1 3は本発明容器の好ま しい製造法の他の例を工程 順に示す説明図である。  FIG. 13 is an explanatory view showing another example of the preferred production method of the container of the present invention in the order of steps.
発明を実施するための最良の形態 本発明の各種実施例を添付図面に基づき説明すると次 の通りである。  BEST MODE FOR CARRYING OUT THE INVENTION Various embodiments of the present invention will be described below with reference to the accompanying drawings.
図 1〜 2は 2本弱シール部タイプの本発明実施の一例 を示している。  1 and 2 show an example of the embodiment of the present invention of a two weak seal portion type.
本実施例によれば、 図 1から明らかなように、 可撓性 プラスチッ ク容器本体 1を具備し、 該容器本体 1 には口 部 2が設けられている。  According to the present embodiment, as is apparent from FIG. 1, a flexible plastic container main body 1 is provided, and the container main body 1 is provided with an opening 2.
プラスチッ ク容器本体 1 は、 重ねられた 2枚の可撓性 プラスチッ クフィ ルム 3、 3を周縁部において溶着する こ とにより得られる。  The plastic container body 1 is obtained by welding two superposed flexible plastic films 3 and 3 at the peripheral edge.
フィ ルム 3 は特殊なものでな く 、 従来から医療分野に おいて、 可撓性プラスチッ ク容器を形成するために一般 に使用されている安価なプラスチッ クフィ ルムが使用さ れる。  The film 3 is not special, and an inexpensive plastic film generally used in the medical field to form a flexible plastic container is used.
フィ ルム 3の一例と して、 図 3 に、 ポ リ エチ レン (以 下 P E と略記する) の外層 3 a と、 P E とポリ プロ ピレ ン (以下 P Pと略記する) とのプレン ドの内層 3 b とか らなる 2層構成のものが示されている。 As an example of film 3, Fig. 3 shows the outer layer 3a of polyethylene (hereinafter abbreviated as PE), PE and polypropylene. (Hereinafter abbreviated as PP) and an inner layer 3b of the blend are shown.
プラスチック容器本体 1には、 図 1に示すように、 高 さ方向の中間部に、 横方向に延出する 2本の弱シール部 8 a 8 bが溶着手段の適用で形成されている。  As shown in FIG. 1, in the plastic container body 1, two weak seal portions 8a and 8b extending in the lateral direction are formed at the intermediate portion in the height direction by applying a welding means.
弱シール部 8 a、 8 bは、 押圧手段などの適用で高め られた容器内圧力を利用して、 適宜開封するためのもの であり、 その溶着強度は、 上記容器本体 1の周縁部の溶 着強度より も小さいことが必要である。  The weak seal portions 8a and 8b are used to appropriately open the container by using the pressure in the container increased by applying a pressing means or the like, and the welding strength is determined by the welding strength of the peripheral portion of the container body 1. It must be smaller than the wearing strength.
プラスチック容器本体 1内は、 弱シール部 8 a、 8 b により上下 2室 1 a, l bに区画される。 上室 1 aを形 成している上容器部 1 Aには、 その周囲を覆うように力 バー 5が設けられ、 下室 1 bを形成している下容器'部 1 Bにはこのような力パー 5は設けられていない。  The interior of the plastic container body 1 is divided into two upper and lower chambers 1a and 1b by weak seal portions 8a and 8b. The upper container section 1A forming the upper chamber 1a is provided with a force bar 5 so as to cover the periphery thereof, and the lower container section 1B forming the lower chamber 1b has such a force bar. No power par 5 is provided.
力パ一 '5は、 水分及びガス非透過性に優れた特殊なフ ィ ルム 6から構成される。 特殊フィルム 6の一例として、 図 5に、 外層 6 a 水分及びガス非透過性に優れたアル ミ ラ ミ ネ一 トフィ ルム、 アルミ蒸着フィ ルム等のアルミ 加工フィ ルムや、 ポリ塩化ビニリデンとポリプロピレン ( P P ) との 2層から構成され、 内層 6 bがポリエチレ ンから構成された多層フィ ルムが示されている。 外層 6 aのう ち、 ポリ塩化ビニリデンはポ リ ビニルァルコ一ル のシ リ カ蒸着フ ィ ルムと置き換えてもよい。 The force pad 5 is composed of a special film 6 having excellent moisture and gas impermeability. As an example of the special film 6, Fig. 5 shows the outer layer 6a.Aluminum processed film such as aluminum film, aluminum vapor-deposited film, etc., which have excellent moisture and gas impermeability, and polyvinylidene chloride and polypropylene ( PP), and a multilayer film in which the inner layer 6b is made of polyethylene. Outer layer 6a, polyvinylidene chloride is polyvinyl alcohol It may be replaced with a silica-deposited film.
カバー 5 は図 1 に示されるよ う に、 上容器部 1 Aの周 囲を覆うように配された 2枚の特殊フィ ルム 6, 6から 構成され、 該フィ ルム 6, 6の周縁部のうち、 上容器部 1 Aと接しない部分は、 フィ ルム 6, 6同士で溶着され、 接する部分は上容器部 1 Aの外表面に対して溶着されて いる。 フィ ルム 6 , 6の下縁溶着部 6 c, 6 c は、 図 4 に示すように、 弱シール部 8 a、 8 bの間に位置してい As shown in FIG. 1, the cover 5 is composed of two special films 6, 6 arranged so as to cover the periphery of the upper container 1A. Of these, the portion not in contact with the upper container 1A is welded between the films 6, 6, and the portion in contact is welded to the outer surface of the upper container 1A. The lower edge welds 6c, 6c of the films 6, 6 are located between the weak seals 8a, 8b as shown in FIG.
O o O o
2本の弱シール部 8 a、 8 b間には、 間隔があり、 こ の間隔部 9には実質的にシールは施されていない。 力バ 一 5の下縁部 6 c は、 弱シール部 8 a、 8 b間の間隔部 9に溶着される。 この溶着状況が図 4に拡大して示ぎれ ている。 力パー 5の下縁部 6 c は、 弱シール部 8 a、 8 b間の間隔部 9に溶着されるので、 溶着操作時に弱シー ル部 8 a、 8 bの溶着強度を増加させるという危険性が なく なる。 1本の弱.シールタイプのものでは、 カバーの 下縁部が、 弱シール部上で容器本体 1に溶着されるので、 弱シール部の溶着強度をできるだけ増加させないか、 ま たは増加させたと してもイージーピール性に支障のない ような条件下で溶着操作を行なう ことが望まれる。 この ような条件設定は、 カバーの材質の選定や溶着温度、 溶 着時間、 溶着圧力等の溶着条件を選択することにより可 能であるが、 かなり限られたものとなる。 図 1及び図 4 に示すような 2本の弱シール部とすれば、 弱シール部 8 a、 8 bの溶着強度への悪影響なしに、 カバー 5の下縁 部 6 cを容器本体 1に対し溶着できるので、 カバーの材 質の選定や、 溶着条件の選択の自由度が、 1本の弱シー ル部の場合より広く なるという利点が得られる。 更に 2 本の弱シール 8 a、 8 b間の間隔部に溶着される力パ一 5の下縁溶着部 6 cは、 図 4から明らかなように、 容器 本体 1の各室 l a, 1 b との距離が比較的大きく なる。 その結果溶着操作時の熱で、 上記室 1 a , 1 b内収容の 薬剤が熱変性される危険性が一榛される。 吸湿性や易酸 化性を有する薬剤のうちには易熱変性のものが多く存在 するが、 このような易熱変性のものでも、 熱変性の危険 性なしに、 カバー 5下端部の容器本体 1への溶着が可能 になる。 また、 誤って外力が加えられ、 1つの弱シール 部が剥離しても他の弱シール部により 2つの室間の連通 が防止できる。 There is a space between the two weak seal portions 8a and 8b, and the space 9 is not substantially sealed. The lower edge 6c of the force bar 5 is welded to the space 9 between the weak seals 8a and 8b. This welding situation is shown in an enlarged scale in FIG. Since the lower edge 6c of the force par 5 is welded to the space 9 between the weak seal portions 8a and 8b, there is a danger of increasing the welding strength of the weak seal portions 8a and 8b during the welding operation. Sex is lost. In the case of a seal type, the lower edge of the cover is welded to the container body 1 on the weak seal, so that the welding strength of the weak seal is not increased or increased as much as possible. However, it is desirable to perform the welding operation under conditions that do not affect easy peelability. Such condition setting depends on the selection of the material of the cover, the welding temperature, and the welding temperature. It is possible by selecting welding conditions such as welding time and welding pressure, but it is quite limited. If two weak seals are used as shown in Fig. 1 and Fig. 4, the lower edge 6c of the cover 5 can be attached to the container body 1 without adversely affecting the welding strength of the weak seals 8a and 8b. Since welding can be performed, there is an advantage that the degree of freedom in selecting the material of the cover and selecting the welding conditions is wider than in the case of a single weak seal portion. Further, the lower edge welded portion 6c of the force pad 5 welded to the space between the two weak seals 8a and 8b is, as is clear from FIG. 4, the respective chambers la and 1b of the container body 1. Is relatively large. As a result, the risk of heat denaturation of the chemicals contained in the chambers 1a and 1b due to heat during the welding operation is alleviated. There are many easily denatured chemicals that have hygroscopicity and easy oxidation, but even those easily denatured without the danger of heat denaturation, the container body at the lower end of the cover 5 Welding to 1 becomes possible. Also, even if an external force is accidentally applied and one weak seal is peeled off, communication between the two chambers can be prevented by the other weak seal.
カバー 5付の上容器部 1 A内に、 吸湿性及び 又は易 酸化性の例えば粉末剤 1 0が収容され、 また力パ一 5な しの下容器部 1 B内に例えば通常の液剤 1 1が収容され o 各部の溶着に当たって溶着温度は、 プラスチッ ク容器 本体 1の全周縁部ならびにカバー 5の上縁部と両側部が 最も高く、 次にプラスチッ ク容器本体 1 とカバー 5の下 縁部との溶着部が高く、 弱シール部 8 a、 8 bは、 これ らのうちで最も低い。 その結果溶着強度は、 上記各部の うち弱シール部 8 a、 8 bが最も弱く なる。 The upper container 1 A with the cover 5 contains a hygroscopic and / or easily oxidizable powder 10, for example, and the lower container 1 B without power 5 contains, for example, a normal liquid 11. Is contained o The welding temperature during welding of each part is highest at the entire peripheral edge of the plastic container body 1 and the upper edge and both sides of the cover 5, and then at the welding point between the plastic container body 1 and the lower edge of the cover 5. High, weak seals 8a, 8b are the lowest of these. As a result, the welding strength of the weak seal portions 8a and 8b becomes the weakest among the above-mentioned portions.
図 6は図 1〜 2に示された本発明容器の好ま しい製造 法の一例を示しこれを図 6の ( a ) 〜 ( e ) に基づき説 明すると、 次の通りである。  FIG. 6 shows an example of a preferred method of manufacturing the container of the present invention shown in FIGS. 1 and 2, which is described below with reference to (a) to (e) of FIG.
図 6 ( a ) に示すように、 先ず最初に、 図 3に示すプ ラスチックフィ ルムを内層 3 b同士を合わせて 2枚重ね、 溶着温度約 1 7 0〜 2 0 0 °Cで 3方の周辺シールを行な いプラスチッ ク容器本体 1を作る。 次に該容器本体 1の 中間部に溶着温度約 1 1 0〜 1 3 0°Cで弱シール部 8 a、 8 bを形成し、 更に、 口部 2を取り付ける。 そして容器 本体 1を上室を形成している上容器部 1 Aと、 下室を形 成している下容器部 1 Bとに分ける。  As shown in Fig. 6 (a), first, two plastic films shown in Fig. 3 are laminated together with the inner layers 3b together, and the three layers are welded at a welding temperature of about 170 to 200 ° C. Make the plastic container body 1 without sealing the periphery. Next, weak sealing portions 8a and 8b are formed in the middle portion of the container body 1 at a welding temperature of about 110 to 130 ° C., and a mouth portion 2 is attached. Then, the container body 1 is divided into an upper container section 1A forming an upper chamber and a lower container section 1B forming a lower chamber.
次に下容器部 1 Bの未シール部よりその内部に液剤 1 1を充填した後、 図 6 (b ) に示すように、 両容器部 1 A, 1 Bの未シール部をシールし、 高圧蒸気滅菌又は熱 水滅菌等の加熱滅菌処理を行なう。  Next, after filling the liquid material 11 from the unsealed part of the lower container part 1B into the inside, as shown in Fig. 6 (b), seal the unsealed parts of both container parts 1A and 1B, and Perform heat sterilization such as steam sterilization or hot water sterilization.
熱滅菌処理を終えた後は、 図 6 (c) に示すように、 上容器部 1 Aの一側部を無菌条件下で力ッ ト し開封し、 次いで必要に応じ、 乾燥処理する。 After the heat sterilization process, as shown in Fig. 6 (c), Forcibly open one side of the upper container 1A under aseptic conditions, and then dry if necessary.
次に図 6 ( d ) に示すように、 上容器部 1 Aに図 5に 示す特殊フィルムを用いてカバー 5の 3方を溶着する。 5 このとき、 弱シール部 8 a、 8 bに沿って溶着する下縁 部 6 cは、 これらの弱シール部の中間の位置とし、 この 弱シール部に重ならないようにして 1 3 0〜 1 3 5でで , 溶着する。 カバー 5の一側部は上容器部 1 Aの一側部と 同様に開口されている。  Next, as shown in FIG. 6 (d), the three sides of the cover 5 are welded to the upper container 1 A using the special film shown in FIG. 5 At this time, the lower edge 6c to be welded along the weak seals 8a and 8b is located at an intermediate position between these weak seals, and is set so as not to overlap with the weak seals. At 3 5, welding is performed. One side of the cover 5 is opened like the one side of the upper container 1A.
10 次に抗生物質等の粉末剤 1 0を無菌条件下で上容器部 10 Next, powder 10 such as antibiotics was added to the upper container under aseptic conditions.
1 A内に収容し、 上容器部 1 A並びに力パー 5の一側部 の開口部分をシールすることにより、 図 6 ( e ) に示す ように、 本発明複室容器が得られる。  The multi-chamber container of the present invention can be obtained as shown in FIG.
なお、 開口部をシールする際、 空間部の酸素を除去す 15 るため、 N。 置換するのが好ましい。 弱シール部の形成 は、 例えば、 加熱された弱シール部形成用金型をシリ ン ダ装置により容器本体に押し当てて行なうことができ、 この金型は、 所定間隔を隔てて配置され電気ヒータによ り温度調節可能とされた 2本の突条を備えたものとする 20 ことができる。  When sealing the opening, N is used to remove oxygen in the space. Substitution is preferred. The weak seal portion can be formed, for example, by pressing a heated weak seal portion forming mold against the container body by a cylinder device, and the mold is disposed at a predetermined interval from an electric heater. It can be provided with two ridges whose temperature can be adjusted.
カバー 5付の容器部 1 A内に液剤を収容し、 カバーな し容器部 1 B内に液剤又は粉末剤を収容する場合は、 例 えば上記製造例と同様な工程で容器本体 1 に口部 2を取 付けた後、 各容器部 1 A, 1 B内に所定の物質を収容し、 更に充填口を閉じた後加熱滅菌を行なう。 加熱滅菌後、 カバー 5を上容器部 1 Aに取付け、 カバーの側部開口を シールすればよい。 For example, if liquid is stored in container 1A with cover 5 and liquid or powder is stored in container 1B without cover For example, after attaching the mouth part 2 to the container body 1 in the same process as in the above production example, a predetermined substance is accommodated in each of the container parts 1A and 1B, and after filling holes are closed, heat sterilization is performed. . After heat sterilization, the cover 5 may be attached to the upper container 1A, and the side opening of the cover may be sealed.
図 6に示された製造例より得られた本発明複室容器に おいては、 上容器部 1 Aは外層が P E、 内層が P E と P P とのブレ ン ドからなるプラスチ ッ ク フィ ルムから構成 されているので、 極く僅かながら水分及びガス (例えば、 酸素) を透過させる。 上容器部 1 Aには、 水分及びガス ノ リア一性の特殊フィ ルムからなるカバー 5が設けられ ているので、 カバー 5の働きで、 上容器部 1 Aの上記弱 点はカバーされる。 而して、 上容器部 1 A内には、 これ がプラスチッ ク製であるに拘らず、 吸湿性及び Z又は易 酸化性の粉末剤を長期保存可能に収容できる。 上下容器 部 1 A, 1 B間を仕切っている弱シール部 8 a、 8 bは、 各部の溶着部のうち、 最も溶着強度の小さい部分であり、 従って容器部を押圧し、 容器内圧力を高めれば、 この圧 力で弱シール部 8 a、 8 bが剥離し、 両容器部 1 A , 1 Bは連通状態となり、 両容器部 1 A , 1 B内に収容され た液剤並びに粉末剤は無菌状態で混合し、 所定の溶液と なる。 上記実施例の粉末剤として例えば、 抗生剤、 抗癌剤、 ステロイ ド剤、 血栓溶解剤、 ビタ ミ ン剤などの吸湿性、 易酸化性及び易熱変性の粉末剤等が挙げられ、 液剤とし てこれらの溶解液又は希釈液、 例えば生理食塩液、 プド ゥ糖液等の液剤が挙げられる。 In the multi-chamber container of the present invention obtained from the production example shown in FIG. 6, the upper container part 1A is made of a plastic film in which the outer layer is made of PE and the inner layer is made of a blend of PE and PP. It is configured to allow very little moisture and gas (eg, oxygen) to permeate. Since the upper container 1A is provided with the cover 5 made of a special film of moisture and gaseous uniformity, the above-mentioned weak point of the upper container 1A is covered by the function of the cover 5. Thus, in the upper container 1A, a hygroscopic and Z- or oxidizable powder can be stored for a long period of time irrespective of whether it is made of plastic. The weak seal portions 8a and 8b, which separate the upper and lower container parts 1A and 1B, are the parts having the lowest welding strength among the welded parts of the respective parts, and therefore press the container part and reduce the pressure in the container. If the pressure is increased, the weak seal portions 8a and 8b are peeled off by this pressure, the two container portions 1A and 1B are in communication with each other, and the liquid material and the powder material contained in the two container portions 1A and 1B are separated. Mix under aseptic conditions to form the desired solution. Examples of the powders of the above examples include hygroscopic, easily oxidizable and easily denatured powders such as antibiotics, anticancer agents, steroids, thrombolytic agents, vitamins and the like. And a solution such as a physiological saline solution and a pseudosugar solution.
プラスチック容器用の通常フィルムとしては、 図 3に 示す構成の多層フィルム以外にも、 P E、 P P及びこれ らの混合樹脂から選ばれる一種以上の組合せによる単層 もしく は多層フィ ルムを使用することも可能である。 例えば、 図 7に示すように、 外層 3 1が直鎖状低密度 ポリエチレン (以下 L L D P Eと略記する) 、 中間層 3 3が L L D P Eと低結晶性 (又は非晶性) のエチレン · α—才レフィ ン系エラス トマ一との混合樹脂、 内層 3 4 が L L D Ρ Εと Ρ Ρとの混合樹脂からなる 3層フィ ルム 3 5を挙げることができる。  As a normal film for plastic containers, besides the multilayer film having the configuration shown in Fig. 3, use a single-layer or multilayer film composed of one or more combinations selected from PE, PP, and their mixed resins. Is also possible. For example, as shown in FIG. 7, the outer layer 31 is composed of linear low-density polyethylene (hereinafter abbreviated as LLDPE), and the middle layer 33 is composed of LLDPE and low-crystalline (or non-crystalline) ethylene / α-polyethylene. And a three-layer film 35 in which the inner layer 34 is made of a mixed resin of LLD Ε and Ρ.
また、 封入する薬剤によっては、 内壁の内層に用いら れる L L D Ρ Εに含まれる低^^子量物質と薬剤が経時的 に相互作用を起こし、 患者に悪影響を及ぼす反応生成物 を生ずる虞れがある。 そこで内層 3 4に用いられる L L D Ρ Εを、 例えばベントペレッ ト法等により高温且つ減 圧下で前処理することによつて炭素数約 3 0以下の低分 子量物質をある特定量以下に除去し、 薬剤と内層フィル ムの相互作用を好適に防止する こ とができ る。 Also, depending on the drug to be enclosed, the drug may interact with the low-molecular-weight substance contained in the LLD used in the inner layer of the inner wall over time, producing a reaction product that adversely affects the patient. There is. Therefore, the LLD used for the inner layer 34 is pretreated at a high temperature and under reduced pressure by, for example, a vent pellet method to remove a low molecular weight substance having about 30 or less carbon atoms to a specific amount or less. The drug and inner layer fill Thus, it is possible to suitably prevent the interaction of the system.
さ らに、 フィ ルムの耐熱性を向上させるために上記 3 層フ ィ ルム 3 5の各層に、 必要に応じて適量の高密度ポ リエチレン (H D P E) を配合すれば、 1 2 1 °C以上に よる高圧蒸気滅菌や熱水滅菌等の高温滅菌に耐える成形 安定性の優れた複室容器を製造するこ とができる。  Furthermore, if an appropriate amount of high-density polyethylene (HDPE) is added to each layer of the three-layer film 35 as needed to improve the heat resistance of the film, the temperature can exceed 121 ° C. Thus, a multi-chamber container with excellent molding stability that can withstand high-temperature sterilization such as high-pressure steam sterilization and hot water sterilization can be manufactured.
カバー用の特殊フィ ルムと しては、 ポリ塩化ビニリデ ン、 ポ リエチレ ンテレフ夕 レー ト (以下 P E Tと略記す る) 、 アル ミ加エフ イ ノレム、 エチレ ン ビニルアルコール 共重合体 (E V O ) 、 シ リ カ蒸着フィ ルムの単層も し く は多層のシ トを使用することも可能である。 なかで も、 シリ カ蒸着フィ ルムは、 透明で且つ水分非透過性及 びガス非透過性に優れているので、 シー トの少なく とも 1層を構成するのが好ま しい。  Special films for the cover include polyvinylidene chloride, polyethylene terephthalate (hereinafter abbreviated as PET), aluminum fluorinolem, ethylene vinyl alcohol copolymer (EVO), It is also possible to use single-layer or multi-layer sheets of the vapor-deposited film. Among them, a silicon vapor-deposited film is transparent and has excellent moisture impermeability and gas impermeability. Therefore, it is preferable to form at least one layer of a sheet.
例えば、 図 8に示すように外層 4 3が 2軸延伸された For example, the outer layer 43 was biaxially stretched as shown in FIG.
P E T. 中間層 4 4がシリ カ蒸着 P V A、 内層 4 5が低 密度ポリエチレン ( L D P E ) であって、 各層間がウレ タン系接着樹脂で固定されている 3層フィ ルム 4 6から なる水分非透過性及びガス非透過性のバリ ア一フィ ルム を挙げる こ とができ る。 PET T. The intermediate layer 44 is silica-deposited PVA, the inner layer 45 is low-density polyethylene (LDPE), and each layer is a three-layer film 46 fixed with urethane-based adhesive resin. Permeable and gas impermeable barrier films can be mentioned.
こ こで、 プラスチ ッ ク容器本体とカバーとを溶着する 場合、 溶着を良好にするために少なく ともカバーを多層 フィ ルムとし、 カバーの最内層の材質とプラスチッ ク容 器本体の最外層の材質とを同一にすることが望ま しい。 例えば、 プラスチッ ク容器本体の最外層が L L D P Eの 場合、 カバーの最内層には L L D P Eを用いることが望 ましい。 Here, when welding the plastic container body and the cover, at least the cover must be multilayered in order to improve the welding. It is desirable that the material of the innermost layer of the cover be the same as the material of the outermost layer of the plastic container body. For example, if the outermost layer of the plastic container body is LLDPE, it is desirable to use LLDPE for the innermost layer of the cover.
前記実施例では力バーで覆われた容器部の室内に粉末 剤を封入し、 カバーで覆われない容器部の室内に液体を 封入したが、 目的に応じて粉末剤を液剤に、 液剤を粉末 剤に変えて封入することも可能である。  In the above embodiment, the powder was sealed in the chamber of the container portion covered with the power bar, and the liquid was sealed in the chamber of the container portion not covered with the cover. It is also possible to enclose instead of the agent.
力パーで覆われた容器部の室内に液剤を封入し、 他の 容器部の室内に粉末剤を封入する例として、 例えば液剤 としてシスティ ン又は ト リブトファンをそれぞれ添加し たァミ ノ酸製剤等の易酸化性の物質が挙げられ、 粉末剤 と して糖もしく は電解質、 又はこれらの」混合物等が挙げ られる。  An example of encapsulating a liquid in a chamber of a container covered with a force par, and enclosing a powder in a chamber of another container, such as an amino acid preparation to which cystine or tritophan is added as a liquid, etc. And a sugar or electrolyte as a powder or a mixture thereof.
カバーで覆われた容器部の室内に液剤を封入し、 他の 容器部の室内に他の液剤を封入する例と しては、 例えば 前者の液剤としてシスティ ン又は ト リ ブトファ ンをそれ ぞれ添加したアミ ノ酸製剤あるいはビタ ミ ン剤の易酸化 性の物質が挙げられ、 後者の液剤と しては糖 ·電解質液 が挙げられる。  As an example of enclosing a liquid in a chamber of a container covered with a cover and another liquid in a chamber of another container, for example, cysteine or tributophane are used as the former liquid, respectively. Examples of the added amino acid preparation include a readily oxidizable substance such as an amino acid preparation and a vitamin preparation, and the latter liquid preparation includes a sugar-electrolyte solution.
また他の例としては、 前者の液剤として脂肪乳剤等の 液酸化性の物質が、 後者の液剤と しては糖 · 電解質液等 が挙げられる。 As another example, the former liquid preparation such as a fat emulsion is used. A liquid oxidizing substance, for the latter liquid agent, is a sugar-electrolyte solution or the like.
さ らに、 いずれか一方の容器部の室内に固形剤を、 他 の容器部の室内に液剤を封入するこ と も可能である。 さ らにまた、 上記粉末剤、 液剤、 固形剤の例と して、 経静 脈又は経腸 (経管、 経口) 投与する他の種々の栄養剤や 治療剤等が挙げられる。  Further, it is also possible to enclose a solid agent in one of the chambers of the container and a liquid agent in the chamber of the other container. Furthermore, examples of the above-mentioned powders, liquids, and solids include various other nutrients and therapeutic agents to be administered intravenously or enterally (tube or oral).
さ らに、 カバーで覆われた容器部の室内に封入される 物質が光劣化性を有する場合には、 カバーの一部又は全 部にアルミ加工フィ ルムを使用し、 内部を遮光するよう にしてもよい。 尚、 カバーに使用されたアルミ加工フィ ルムは、 使用時必要に応じその一部又は全部が剥離可能 であってもよい。  In addition, if the substance enclosed in the chamber of the container part covered with the cover has photodegradability, use aluminized film on part or all of the cover to shield the inside from light. You may. In addition, the aluminum processed film used for the cover may be partly or entirely peelable as needed at the time of use.
さ らに、 前記実施例は液剤と 1種の粉末剤とを封入す る 2室容器の例であるが、 2室以上でも適用可能である。 図 9にその一例を示す。 カバー 5内には 2種の粉末剤 (又は粉末剤と固形剤) を封入する室 1 aェ , 1 & 2 を 有する容器部 1 A ' が配置されている。 カバーなし容器 部 1 B内には液剤 1 1が収容されている。 粉末剤や固形 剤に限らず液剤を封入する室を複数個設けるこ とも可能 である。 これらの室間の仕切り部にも弱シール部を設け る o カバーにより覆われた室 1 aに易酸化性を有する液剤、 粉末材もしく は固形剤を封入する場合は、 容器本体 1 と 力パー 5との空間部には窒素ガス、 炭酸ガス、 アルゴン ガス等の不活性ガスを封入するのが望ま しい。 また室 1 aに吸湿性を有する液剤、 粉末材もしく は固形剤を封入 する場合は、 前記空間部にほ乾燥空気、 乾燥窒素ガス等 の乾燥ガスを封入するのが望ましい。 不活性ガスを封入 した場合は前記空間部内の空気を不活性ガスで置換する ので酸化防止の効果がざらに確実と-なり、 乾燥ガスを封 入した場合は前記空間部内の空気が乾燥ガスと置換され るので、 防湿効果がさらに確実となる。 Further, the above-described embodiment is an example of a two-chamber container enclosing a liquid agent and one kind of powder agent, but can be applied to two or more chambers. Figure 9 shows an example. Inside the cover 5, a container 1A 'having chambers 1a and 1 & 2 for enclosing two kinds of powders (or a powder and a solid) is arranged. Liquid material 11 is stored in container part 1B without a cover. Not only powders and solids but also multiple chambers for liquids can be provided. Provide a weak seal at the partition between these chambers.o When a liquid material, powder material, or solid material that is easily oxidizable is sealed in the chamber 1a covered with the cover, nitrogen gas, carbon dioxide gas, and argon gas should be filled in the space between the container body 1 and the force par 5. It is desirable to fill an inert gas such as. When a liquid material, a powder material or a solid material having a hygroscopic property is sealed in the chamber 1a, it is preferable that a dry gas such as dry air or dry nitrogen gas is sealed in the space. When the inert gas is sealed, the air in the space is replaced with the inert gas, so that the effect of preventing oxidation is roughly ensured.When the dry gas is sealed, the air in the space is replaced with the dry gas. Since it is replaced, the moisture-proof effect is further ensured.
このように、 容器本体における防湿や酸化防止を必要 とされる室を水分及びガス非透過性フィルムでカバーす ることにより、 さらには、 容器本体とカバ一との空間部 に不活性ガスや乾燥ガスを封入したりすることにより、 従来の如く該空間部に脱酸素剤及び乾燥剤を入れなくて も、 高い薬剤の経時安定性を達成することができる。  In this way, by covering the chamber in the container body where moisture proofing and oxidation prevention are required with the moisture and gas impermeable film, the space between the container body and the cover can be further protected by inert gas or drying. By sealing gas or the like, high stability over time of the drug can be achieved without adding an oxygen scavenger and a desiccant in the space as in the related art.
なお、 弱シール部は 2本のものに限らず、 2本以上と することもでき、 1本としてもよい。 さらに、 弱シール 部は、 必ずしも直線である必要はなく、 例えば、 カバー で覆われた室の中央部付近が突出するような V字形状と してもよい。 こうすると、 使用時に一方の室に手で押圧 力を加えた場合、 弱シール部を引き剥がそう とする力が V字形部分に集中するので、 比較的小さな押圧力で弱シ 一ル部を剥がして薬剤の混合を行なう こ とができる。 但 し、 この場合は、 複室容器の保存又は輸送中の不慮の剥 離を引き起こす虞れがあるので、 溶着条件を特に吟味す るのが望ま しい。 The number of weak seal portions is not limited to two, but may be two or more, or may be one. Further, the weak seal portion does not necessarily have to be a straight line, and for example, may have a V-shape such that the vicinity of the center of the chamber covered with the cover projects. In this way, you can press on one of the chambers by hand during use When a force is applied, the force for peeling off the weak seal concentrates on the V-shaped portion, so that the medicine can be mixed by peeling the weak seal with a relatively small pressing force. However, in this case, there is a risk of inadvertent peeling during storage or transportation of the multi-chamber container, so it is desirable to particularly examine the welding conditions.
また、 前記実施例では、 弱シール部の形成は容器本体 を構成する 2枚のシー トの内面同士を直接溶着する、 い わゆる直接溶着方式で行なっているが、 これに代えてこ のシー小間に多層イ ンサー トフ ィ ルムを挟んだ状態で溶 着し、 弱シール部を形成させる、 いわゆる多層イ ンサー トフィ ルム挟持溶着方式で行なつてもよい。 図 1 0 は 2 層イ ンサー トフ ィ ルムを使用した例を示す。 この場^ 3 は単層フィ ルム又は多層フィ ルムからなる容器形成のフ イ ルムであり、 1 8 は上記フィ ルム 3の最内層に対して 熱接着力の強いシー ト、 1 9 は反対側のフィ ルム 3の最 内層に対して熱接着力の弱いシー トであり、 それらの間 に弱シール部 2 1 a、 2 1 bが形成されている。 例えば、 上記フィ ルム 3が P E又は P Pの単層フィ ルムである場 合には、 1 8はこれと同じ P E又は P Pのシー トであり、 1 9は P E と P P との混合樹脂である。 2 1 a、 2 1 b は弱シール部である。 イ ンサー トフィ ルムは各弱シール 部に合わせて二分しても良い。 また、 カバー 1 2の溶着 は多層ィンサ一トフイルムの弱シール部に重ねて溶着し てもよいが、 容器本体の弱シール性を保持することが条 件とされる。 カバーはまた、 接着剤や粘着剤で容器本体 5 に接着してもよい。 In the above-described embodiment, the weak seal portion is formed by a so-called direct welding method in which the inner surfaces of two sheets constituting the container body are directly welded to each other. A so-called multilayer insert film sandwiching welding method may be used in which the multilayer insert film is welded to form a weakly sealed portion while sandwiching the multilayer insert film. Figure 10 shows an example using a two-layer insert film. In this case, ^ 3 is a film for forming a container consisting of a single-layer film or a multilayer film, 18 is a sheet having a strong thermal adhesion to the innermost layer of the above-mentioned film 3, and 19 is the opposite side. This is a sheet having a low thermal adhesive force to the innermost layer of the film 3 and weak seal portions 21a and 21b are formed between them. For example, when the film 3 is a single-layer film of PE or PP, 18 is the same sheet of PE or PP, and 19 is a mixed resin of PE and PP. 21a and 21b are weak seal portions. Insert film is weak seal It may be bisected according to the part. In addition, the cover 12 may be welded over the weak seal portion of the multilayered ink film, but the condition is that the weak sealing property of the container body is maintained. The cover may also be adhered to the container body 5 with an adhesive or an adhesive.
なお、 本発明の複室容器を保存又は輸送する場合には、 図 1 1に示すように弱シール部 8 a、 8 bで二つ折りに して外装袋 5 0に封入することが好ましい。 このように 二つ折りにすれば、 保存時の積み重ねによる重圧或いは " 10 落下等の外力による弱シール部の不必要な剥離を防止す ることができる。  When the multi-chamber container of the present invention is stored or transported, it is preferable that the container be folded in two at the weak seal portions 8a and 8b and sealed in the outer bag 50 as shown in FIG. In this way, by folding in two, unnecessary peeling of the weak seal portion due to heavy pressure due to stacking during storage or external force such as “10 drop” can be prevented.
また、 図 1 2に示すように口'部 2 ' を抗生物質等の粉 末薬剤 1 0を収容する室 1 a ' に設け、 溶解液等の薬剤 1 1を収容する室 1 b ' を閉塞するようにしてもよい。 15 溶解液等の液剤を収容する室に口部を設けている場合に は、 緊急の場合に誤って混合操作をすることなく溶解液 等の液剤だけを先に投与してしまう危険があるが、 上述 のように口部 2 ' を抗生物質等の粉末薬剤を収容した室 に取り付けることによって、 上記のような危険を回避で - 20 きる利点がある。  In addition, as shown in Fig. 12, the mouth 'portion 2' is provided in the chamber 1a 'for containing the powdered drug 10 such as an antibiotic, and the chamber 1b' for containing the drug 11 such as a solution is closed. You may make it. 15 If an opening is provided in the chamber that contains the solution such as the solution, there is a risk that in the case of an emergency, only the solution such as the solution is administered first without performing the mixing operation by mistake. However, as described above, by attaching the mouth 2 ′ to a room containing a powder drug such as an antibiotic, there is an advantage that the above danger can be avoided.
次に、 本発明容器の好ましい他の製造法を、 図 1 3 ( a ) 〜 ( j ) にもとづき説明する。 図 1 3 ( a ) に示すよ う に、 図 3に示す 2層タイ プの プラスチッ クフィ ルム 3に口部用の孔 2 aを穿孔する。 Next, another preferred method for producing the container of the present invention will be described with reference to FIGS. 13 (a) to 13 (j). As shown in FIG. 13 (a), a hole 2a for a mouth portion is formed in a two-layer type plastic film 3 shown in FIG.
次いで図 1 3 ( b ) に示すよ う にフィ ルム 3の外層即 ち P E側において、 孔 2 aに口部 2を溶着手段の適用で 取付けた後に、 図 1 3 ( c ) に示すように、 口部 2を中 心にフ ィ ルム 3を折り曲げ 2枚重ねの状態にする。  Next, as shown in Fig. 13 (b), after the mouth 2 is attached to the hole 2a by applying welding means on the outer layer of the film 3, that is, on the PE side, as shown in Fig. 13 (c). Then, the film 3 is folded around the mouth 2 so that two sheets are stacked.
次いで図 1 3 ( d ) に示すように、 2枚重ねにしたフ イ ルム 3の周縁部を、 薬液及び粉末剤の充填口 3 5 , 3 6を残して、 溶着温度約 1 7 0〜 2 0 0 °Cでシールし、 プラスチッ ク容器本体 1を得る。  Next, as shown in Fig. 13 (d), the periphery of the two stacked films 3 is welded at a welding temperature of about 170 to 2 mm, leaving the filling ports 35 and 36 for chemicals and powders. Seal at 0 ° C to obtain plastic container body 1.
なお、 充填口 3 5, 3 6のうち、 充填口 3 5は後のェ 程で形成してもよい。  The filling port 35 among the filling ports 35 and 36 may be formed in a later step.
次いで図 1 3 ( e ) に示すように、 上記容器本体 1の 中間部に、 間隔部 3 9を存して平行する 2本の弱シール 部 8 a、 8 bを、 溶着温度約 1 1 0〜 1 3 0 °Cで形成す る。 弱シール部の幅は、 弱シ一ル部 8 bは 1 0 mm、 弱シ ール部 8 aは 5mm程度が適当である。  Next, as shown in FIG. 13 (e), two weak seal portions 8 a and 8 b which are parallel to each other with an interval portion 39 are provided at an intermediate portion of the container body 1, with a welding temperature of about 110. Formed at ~ 130 ° C. The appropriate width of the weak seal part is about 10 mm for the weak seal part 8b, and about 5mm for the weak seal part 8a.
次に図 1 3 ( f ) に示すように、 弱シール部 8 a、 8 bを介し仕切られている上下容器部 1 A, 1 Bの う ち、 下容器部 1 B内に充填口 3 6を通じ液剤 1 1を充填した 後、 両充填口 3 5, 3 6をシールし、 高圧蒸気滅菌を行 な う。 次に図 1 3 ( g ) に示すように、 滅菌終了後、 容器本 体 1の外部を乾燥すると共に、 充填口 3 5の部分を無菌 状態下で力ッ ト し、 充填口 3 5を再び開口し、 該ロ 3 5 を通じ、 上容器部 1 A内を清浄エアの吹込みで乾燥清浄 化する。 Next, as shown in Fig. 13 (f), of the upper and lower container parts 1A and 1B separated by the weak seal parts 8a and 8b, the filling port 36 is provided in the lower container part 1B. After filling the liquid material 11 through, both filling ports 35 and 36 are sealed, and high-pressure steam sterilization is performed. Next, as shown in Fig. 13 (g), after completion of the sterilization, the outside of the container body 1 is dried, and the filling port 35 is urged under aseptic conditions to refill the filling port 35. Open, and the inside of upper container 1A is dried and cleaned by blowing clean air through b.
次いで、 図 1 3 ( h ) に示すように充填口 3 5を通じ 上容器部 1 A内に粉末剤 1 0を無菌条件下で充填し、 充 填後、 充填口 3 5をシールする。  Next, as shown in FIG. 13 (h), the powder 10 is filled under aseptic conditions into the upper container 1A through the filling port 35, and after filling, the filling port 35 is sealed.
次いで、 図 1 3 ( i ) に示すように、 上容器部 1 Aの 周囲を覆うように、 図 5に示された特殊フィ ルム 6を用 いて、 力バ一 5~を設ける。 フィ ルム 6, 6のうち、 一方 は透明であり、 他方は不透明であることが好ましい。  Next, as shown in FIG. 13 (i), a power bar 5 is provided using the special film 6 shown in FIG. 5 so as to cover the periphery of the upper container 1A. Preferably, one of the films 6, 6 is transparent and the other is opaque.
フィ ルム 6 , 6を上容器部 1 Aの縁部に溶着する際、 充填された薬剤 1 0に熱が実質的に及ばないようにする ために、 上記フィルム 6, 6の溶着部 6 bと、 上容器部 1 Aの室 1 a内との間に、 約 5 mm程度の間隔をあけるこ とが好ましい。 この目的のために、 上容器部 1 Aの周縁 特に両側部の溶着部 l A t (図 h参照) の幅は 5 mmより 大きいことが必要であり、 通常はフィ ルム 6の溶着幅を 見込んで 7〜 1 0 mm程度に設定される。 When the films 6, 6 are welded to the edge of the upper container portion 1A, the welded portions 6b of the films 6, 6 are formed so that the heat does not substantially reach the filled drug 10. It is preferable to leave an interval of about 5 mm between the upper container 1A and the chamber 1a. For this purpose, the width of the welded portion l A t the peripheral especially both side portions of the upper container section 1 A (see FIG h) is required to be greater than 5 mm, typically expects the welding width of Fi Lum 6 Is set to about 7 to 10 mm.
また、 図 4に示したようにカバー 5を構成するフ ィ ル ム 6の下縁部 6 cは、 2本の弱シール部 8 a、 8 b間の 間隔部 9の位置に溶着される。 溶着温度は、 フ ィ ルム 6 と して透明なものを用いる場合は、 約 1 5 0〜 1 7 0 °C で溶着され、 不透明なアルミ加工フ ィ ルムを用いる場合 は 1 3 0〜 1 5 0 °Cで溶着される。 In addition, as shown in FIG. 4, the lower edge 6c of the film 6 constituting the cover 5 is provided between the two weak seal portions 8a and 8b. It is welded to the position of the gap 9. The welding temperature is about 150 to 170 ° C when using a transparent film 6, and 130 to 15 when using an opaque aluminized film. Welded at 0 ° C.
図 1 3 ( i ) に示すように、 上容器部 1 Aに設けられ たカバー 5 は当初は一側部が一部開口されており、 この 開口部 4 0を通じ、 カバー 5 と上容器部 1 A間の空間部 7内に不活性ガス又は乾燥ガスを注入した後、 開口部 4 0をシールすることにより、 図 1 3 ( j ) に示すように、 2本弱シール部タイプの本発明複室容器が得られる。 なお、 上記製造例において、 各溶着温度は、 フ ィ ルム の材質及び溶着強度の設定等により、 それぞれ最適な温 度範囲が選択される ものであり、 上記溶着温度範囲に、 何ら限定される ものではない。  As shown in Fig. 13 (i), the cover 5 provided on the upper container 1A is initially partially open on one side, and through this opening 40, the cover 5 and the upper container 1 are opened. After injecting an inert gas or a dry gas into the space 7 between A, the opening 40 is sealed, and as shown in FIG. A chamber container is obtained. In the above manufacturing examples, the optimum temperature range is selected for each welding temperature depending on the material of the film, the setting of the welding strength, and the like, and is not limited to the above-mentioned welding temperature range. is not.
以上、 本発明のいくつかの実施例について説明したが、 本発明はこのよ うな実施例に何等限定される ものではな く、 本発明の要旨を逸脱しない範囲において種々なる態 様で実施し得ることは勿論である。  Although several embodiments of the present invention have been described above, the present invention is not limited to such embodiments and can be implemented in various modes without departing from the scope of the present invention. Of course.

Claims

請 求 の 範 囲  The scope of the claims
1 液剤、 粉末剤もしくは固形剤を収容するための複数 の室を備えていると共に各室間が適宜連通可能な仕切り 手段によって仕切られた複室容器であって、 可撓性のプ 5 ラスチック容器本体を具備し、 該容器本体により形成さ れた複数の室のうち、 少なく とも 1つの室は該室の周囲 に密閉空間部を形成するように周縁部をシールされた力 バーにより覆われ、 他の室はカバーなしであり、 前記力 パーは水夯及びガスバリアー性の可撓性フイルムから構 10 成されており、 前記連通可能な仕切り手段は、 内圧を高 めるように前記室が柙圧されることにより容易に剥離し 得る少なく とも 1本の弱シール部により形成されている ことを特徴とする複室容器。  (1) A flexible plastic container which is provided with a plurality of chambers for accommodating a liquid agent, a powder agent, or a solid agent, and is partitioned by a partition means capable of appropriately communicating between the chambers. A plurality of chambers formed by the container body, at least one of the chambers is covered with a force bar having a peripheral portion sealed to form a sealed space around the chamber; The other chamber is uncovered, the force par is made of a flexible film having water and gas barrier properties, and the communicable partitioning means is provided in the chamber so as to increase the internal pressure. A multi-chamber container characterized by being formed by at least one weak seal portion which can be easily peeled off when pressed.
2 前記弱シール部が、 間隔をおいて少なく とも 2本設 15 けられ、 前記力バ一の端縁が、 隣り合う前記弱シール部 の間に溶着されている請求の範囲第 1項に記載の複室容  2.The weak seal portion according to claim 1, wherein at least two of the weak seal portions are provided at an interval, and an edge of the force bar is welded between the adjacent weak seal portions. Double room
3 前記容器本体と前記カバーとの間の密閉空間部に不 活性ガスもしく は乾燥ガスが封入されている請求の範囲 - 20 第 1項に記載の複室容器。 3. The multi-chamber container according to claim 1, wherein an inert gas or a dry gas is sealed in a sealed space between the container body and the cover.
4 前記カバーで覆われた室に易酸化性及び Z又は吸湿 性を有する液剤、 粉末剤もしく は固形剤を収容した請求 の範囲第 1項に記載の複室容器。 (4) A liquid, powder, or solid agent having oxidizability and Z or hygroscopicity is contained in a chamber covered with the cover. 2. The multi-chamber container according to item 1 above.
5 前記弱シール部が、 プラスチッ ク容器本体を形成し ている可撓性プラスチッ クフィ ルムの内面同士を直接溶 養することにより形成されている請求の範囲第 1項に記 5 載の複室容器。  5.The multi-chamber container according to claim 1, wherein the weak seal portion is formed by directly welding inner surfaces of flexible plastic films forming the plastic container body. .
6 前記弱シール部が、 プラスチッ ク容器本体を形成し ている可撓性プラスチッ クフィ ルムの内面を、 該内面同 士間に挟持されたイ ンサー ト フ ィ ルムを介し溶着するこ とにより、 形成されている請求の範囲第 1項に記載の複 (6) The weak seal portion is formed by welding the inner surface of the flexible plastic film forming the plastic container main body via the insert film sandwiched between the inner surfaces. Of claim 1
10 室容器。 10 chamber container.
7 プラスチッ ク容器本体を形成している可撓性プラス チッ クフィ ルムが、 直鎖状低密度ポリエチレンからなる 外層、 直鎖伏低密度ポリエチレ ンとエチレ ン · α —ォ レ フィ ン系エラス トマ一との混合樹脂からなる中間層、 及 7 The flexible plastic film forming the plastic container body is composed of an outer layer made of linear low-density polyethylene, linear low-density polyethylene, and ethylene-α-olefin elastomer. An intermediate layer made of a resin mixed with
15 び直鎖状低密度ポリエチレンとポリ プロ ピレンとの混合 樹脂からなる内層を備えている請求の範囲第 1項に記載 の複室容器。 15. The multi-chamber container according to claim 1, comprising an inner layer made of a mixed resin of linear low-density polyethylene and polypropylene.
8 前記カバーが、 シリ カ蒸着樹脂層を備えている請求 の範囲第 1項に記載の複室容器。  8. The multi-chamber container according to claim 1, wherein the cover includes a silica-deposited resin layer.
- 20 9 前記カバーが、 2軸延伸されたポ リ エチレ ンテ レフ 夕 レー トの外層、 シリ カ蒸着ポリ ビニルアルコールの中 間層、 及び低密度ポリエチレンの内層を備えている請求 の範囲第 1項に記載の複室容器。 -209 The claim wherein the cover comprises an outer layer of biaxially stretched polyethylene latex, an intermediate layer of silica-deposited polyvinyl alcohol, and an inner layer of low density polyethylene. 2. The multi-chamber container according to item 1 above.
1 0 前記外壁が、 外側の面にアルミ ラ ミネー トフィル ムを備えている請求の範囲第 1項に記載の複室容器。 1 1 前記易酸化性及び Z又は吸湿性を有する薬剤が抗 生物質である請求の範囲第 4項に記載の複室容器。  10. The double-chamber container according to claim 1, wherein the outer wall has an aluminum laminate film on an outer surface. 11. The multi-chamber container according to claim 4, wherein the drug having oxidizability and Z or hygroscopicity is an antibacterial substance.
PCT/JP1993/000558 1992-05-03 1993-04-28 Vessel having a plurality of chambers WO1993021890A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE69325801T DE69325801T2 (en) 1992-05-03 1993-04-28 CONTAINERS WITH A VARIETY OF CHAMBERS
RU93058573A RU2103987C1 (en) 1992-05-03 1993-04-28 Multiple-chamber vessel
CA002112661A CA2112661C (en) 1992-05-03 1993-04-28 Vessel having a plurality of chambers
DK93911945T DK0639364T3 (en) 1992-05-03 1993-04-28 Container with a number of chambers
EP93911945A EP0639364B1 (en) 1992-05-03 1993-04-28 Container having a plurality of chambers
AU42709/93A AU654442B2 (en) 1992-05-03 1993-04-28 Vessel having a plurality of chambers
US08/170,215 US5423421A (en) 1992-05-03 1993-04-28 Containers having plurality of chambers
KR1019940700005A KR100209830B1 (en) 1992-05-03 1993-04-28 Vessel having a plurality of chambers
NO934910A NO303815B1 (en) 1992-05-03 1993-12-30 Container with several chambers
FI935972A FI107694B (en) 1992-05-03 1993-12-31 Containers comprising a plurality of chambers for housing preparations
GR990402171T GR3031088T3 (en) 1992-05-03 1999-08-26 Vessel having a plurality of chambers.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4/140113 1992-05-03
JP14011392 1992-05-03
JP6466993A JP3079403B2 (en) 1992-05-03 1993-02-28 Double chamber container
JP5/64669 1993-02-28

Publications (1)

Publication Number Publication Date
WO1993021890A1 true WO1993021890A1 (en) 1993-11-11

Family

ID=26405772

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1993/000558 WO1993021890A1 (en) 1992-05-03 1993-04-28 Vessel having a plurality of chambers

Country Status (21)

Country Link
EP (1) EP0639364B1 (en)
JP (1) JP3079403B2 (en)
CN (1) CN1065742C (en)
AT (1) ATE182464T1 (en)
AU (1) AU654442B2 (en)
CA (1) CA2112661C (en)
DE (1) DE69325801T2 (en)
DK (1) DK0639364T3 (en)
EG (1) EG20103A (en)
ES (1) ES2133399T3 (en)
FI (1) FI107694B (en)
GR (1) GR3031088T3 (en)
HU (1) HU216406B (en)
NO (1) NO303815B1 (en)
PH (1) PH31343A (en)
PL (1) PL172973B1 (en)
PT (1) PT101262B (en)
RU (1) RU2103987C1 (en)
SG (1) SG44684A1 (en)
TW (1) TW216768B (en)
WO (1) WO1993021890A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462526A (en) * 1993-09-15 1995-10-31 Mcgaw, Inc. Flexible, sterile container and method of making and using same
WO2010081174A2 (en) * 2009-01-12 2010-07-15 Aktivpak, Inc. Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith
EP2226058B2 (en) 1994-03-29 2016-01-20 Fresenius AG Medical multiple chamber polymer bag having compartments separated by a pealable seal
CN114194576A (en) * 2021-02-08 2022-03-18 杭州圣石科技股份有限公司 Sealed moisture-proof package capable of realizing free exchange of internal gas and process

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3455789B2 (en) * 1995-02-28 2003-10-14 株式会社大塚製薬工場 Film for multi-chamber container and multi-chamber container
JP3016348B2 (en) * 1995-03-23 2000-03-06 株式会社ニッショー Double chamber container
JP3419139B2 (en) 1995-04-11 2003-06-23 ニプロ株式会社 Flexible multi-chamber container
JP2734413B2 (en) * 1995-07-04 1998-03-30 株式会社ニッショー Infant beverage container
DE19655056C2 (en) * 1996-01-10 2001-03-01 Nutrichem Diaet & Pharma Gmbh Disposable bag for storing e.g. blood, blood plasma, etc.
SE9601348D0 (en) * 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
EP1579839B1 (en) * 1996-05-13 2013-10-23 B. Braun Medical, Inc. Flexible container and method of making same
SE9602818D0 (en) * 1996-07-19 1996-07-19 Pharmacia & Upjohn Ab Colored composition
GB9705455D0 (en) * 1997-03-17 1997-05-07 Ucb Sa Self-rehydrating container
WO1999021527A1 (en) * 1997-10-27 1999-05-06 Otsuka Pharmaceutical Factory, Inc. Packaged ophthalmic perfusate and cleaning fluid bag
JPH11128315A (en) 1997-11-04 1999-05-18 Material Eng Tech Lab Inc Medical container
DE19751489A1 (en) * 1997-11-20 1999-05-27 Nutrichem Diaet & Pharma Gmbh Double bag for application of a fluid substance
JP4768898B2 (en) * 1998-11-30 2011-09-07 味の素株式会社 Method for producing medical drug enclosure and container therefor
US20050194060A1 (en) 2004-03-03 2005-09-08 Vincent Houwaert Peelable seal closure assembly
US7678097B1 (en) 1999-11-12 2010-03-16 Baxter International Inc. Containers and methods for manufacturing same
US8343128B2 (en) * 2002-04-30 2013-01-01 Otsuka Pharmaceutical Factory, Inc. Multiple-chamber medical container and bag for enclosing same
JP4093004B2 (en) * 2002-09-27 2008-05-28 株式会社デンソー Connector insertion device and method
WO2004080370A1 (en) * 2003-03-12 2004-09-23 Fujimori Kogyo Co., Ltd. Multiple compartment container
US7243787B2 (en) 2003-03-26 2007-07-17 Nipro Corporation Medicine bag
FR2859625B1 (en) * 2003-09-11 2006-05-05 Christiane Cinqualbre FLEXIBLE CONTAINER FOR EXTERNAL PREPARATION AND ADMINISTRATION OF A LIQUID PRODUCT, IN PARTICULAR A MEDICAMENT SOLUTE
JP4336960B2 (en) * 2003-10-20 2009-09-30 株式会社大塚製薬工場 Multi-chamber container
DE10349089B3 (en) 2003-10-22 2005-06-30 Kpss-Kao Professional Salon Services Gmbh Packaging and method for producing a packaging
JP4587096B2 (en) * 2004-03-03 2010-11-24 有限会社ケーアールビジネス Medical multi-chamber container with unmixing prevention mechanism
JP4599918B2 (en) * 2004-07-09 2010-12-15 味の素株式会社 Drug storage sealing body and method for forming drug storage sealing body
KR101211552B1 (en) * 2004-08-16 2012-12-12 니프로 가부시키가이샤 Medical multi-layered container and plural chamber container
US8703706B2 (en) 2005-04-28 2014-04-22 Novo Nordisk Healthcare Ag Closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
DE102005028068B4 (en) * 2005-06-16 2016-07-14 Georg Menshen Gmbh & Co. Kg Method for filling a bag-shaped container
JP5118838B2 (en) * 2006-03-31 2013-01-16 株式会社大塚製薬工場 Multi-chamber container
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
WO2007136062A1 (en) * 2006-05-23 2007-11-29 Nipro Corporation Container
EP2035059B1 (en) 2006-06-15 2015-11-18 Metpro AB Container, system and method for providing a solution
WO2009113177A1 (en) 2008-03-14 2009-09-17 株式会社大塚製薬工場 Plastic ampule and colored plastic container
CN101543461B (en) * 2008-03-28 2013-07-31 丽珠集团利民制药厂 Notoginseng triterpenes medical liquor soft package
JP4944850B2 (en) * 2008-08-08 2012-06-06 味の素株式会社 Drug pre-preparation method
EP2253735B1 (en) * 2009-05-13 2017-11-22 SiO2 Medical Products, Inc. Vessel processing
DE102009058445B4 (en) * 2009-12-16 2016-09-15 Fresenius Medical Care Deutschland Gmbh Multi-chamber bags
JP5104884B2 (en) * 2010-01-27 2012-12-19 味の素株式会社 Method for producing medical drug enclosure and container therefor
KR101935769B1 (en) * 2011-01-31 2019-01-08 이에이 파마 가부시키가이샤 Multi-chambered container
WO2012121094A1 (en) * 2011-03-04 2012-09-13 学校法人久留米大学 Albumin-containing intravenous injection
FR2980180B1 (en) 2011-09-21 2015-01-16 Oreal SACHET HAS AT LEAST TWO COMPARTMENTS
FR2981832B1 (en) * 2011-10-28 2013-12-06 Oreal WELDED SACHET
BR112017021137B1 (en) * 2015-04-30 2022-04-19 Cryovac, Llc Package, packaged product, method of releasing at least one agent into the chamber part of the package, and packaging process
FR3058638B1 (en) * 2016-11-16 2022-01-14 Technoflex DOUBLE COMPARTMENT MEDICAL POUCH WITH TAB
CN106924042B (en) * 2017-04-12 2019-08-20 中国人民解放军联勤保障部队第九八三医院 Novel transfusion bag
CN106901984B (en) * 2017-04-28 2019-06-04 济南市儿童医院(山东大学齐鲁儿童医院) Novel transfusion bag
CN107985803A (en) * 2017-12-21 2018-05-04 蓝栋林 A kind of novel wet tissue
EP3824864A1 (en) * 2019-11-19 2021-05-26 Holger Rupprecht Multi-chamber container

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01240469A (en) * 1988-03-17 1989-09-26 Material Eng Tech Lab Inc Container with content and its manufacture
JPH03236847A (en) * 1990-02-14 1991-10-22 Material Eng Tech Lab Inc Drug-contained receptacle having plural chambers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1486639A1 (en) * 1963-02-23 1969-11-20 Arthur Corella Packaging divided into closed compartments
US3749620A (en) * 1969-11-20 1973-07-31 American Cyanamid Co Package for plural reactable components with rupturable ultrasonic seal
JPS57206447A (en) * 1981-06-12 1982-12-17 Terumo Corp Plastic container receiving liquid drug pasturized with high pressure steam and production thereof
JPS5984719A (en) * 1982-10-30 1984-05-16 テルモ株式会社 Manufacture of plastic vessel containing chemical which do not deteriorate for prolonged term
JPS6011160A (en) * 1983-06-30 1985-01-21 Shimadzu Corp Moisture analysis meter
US4496046A (en) * 1983-09-15 1985-01-29 Baxter Travenol Laboratories, Inc. Multiple chamber container with inner diaphragm and intermediate chamber
US4731053A (en) * 1986-12-23 1988-03-15 Merck & Co., Inc. Container device for separately storing and mixing two ingredients
WO1988008694A1 (en) * 1987-05-07 1988-11-17 Terumo Kabushiki Kaisha Packed transfusion
JPH01240468A (en) * 1988-03-11 1989-09-26 Mitsui Toatsu Chem Inc Packaging body of raw pineapple
JPH0639713Y2 (en) * 1989-12-19 1994-10-19 石塚硝子株式会社 Infusion bag
CZ3869U1 (en) * 1990-11-07 1995-09-26 Otsuka Pharmaceutical Factory, Inc. Storage bin with plurality of chambers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01240469A (en) * 1988-03-17 1989-09-26 Material Eng Tech Lab Inc Container with content and its manufacture
JPH03236847A (en) * 1990-02-14 1991-10-22 Material Eng Tech Lab Inc Drug-contained receptacle having plural chambers

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462526A (en) * 1993-09-15 1995-10-31 Mcgaw, Inc. Flexible, sterile container and method of making and using same
EP2226058B2 (en) 1994-03-29 2016-01-20 Fresenius AG Medical multiple chamber polymer bag having compartments separated by a pealable seal
WO2010081174A2 (en) * 2009-01-12 2010-07-15 Aktivpak, Inc. Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith
WO2010081174A3 (en) * 2009-01-12 2010-10-14 Aktivpak, Inc. Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith
US10981713B2 (en) 2009-01-12 2021-04-20 Aktivax, Inc. Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith
CN114194576A (en) * 2021-02-08 2022-03-18 杭州圣石科技股份有限公司 Sealed moisture-proof package capable of realizing free exchange of internal gas and process
CN114194576B (en) * 2021-02-08 2023-08-25 杭州圣石科技股份有限公司 Sealed moistureproof package capable of realizing free exchange of internal gas and process

Also Published As

Publication number Publication date
JP3079403B2 (en) 2000-08-21
ATE182464T1 (en) 1999-08-15
HU9400012D0 (en) 1994-05-30
CA2112661A1 (en) 1993-11-11
ES2133399T3 (en) 1999-09-16
PT101262B (en) 1999-10-29
TW216768B (en) 1993-12-01
HU216406B (en) 1999-06-28
CN1082881A (en) 1994-03-02
NO934910D0 (en) 1993-12-30
PT101262A (en) 1994-06-30
PH31343A (en) 1998-07-17
EG20103A (en) 1997-07-31
AU654442B2 (en) 1994-11-03
FI935972A0 (en) 1993-12-31
EP0639364A4 (en) 1994-10-24
HUT68420A (en) 1995-06-28
CN1065742C (en) 2001-05-16
DK0639364T3 (en) 1999-11-29
RU2103987C1 (en) 1998-02-10
EP0639364B1 (en) 1999-07-28
NO303815B1 (en) 1998-09-07
PL298768A1 (en) 1994-03-21
DE69325801D1 (en) 1999-09-02
SG44684A1 (en) 1997-12-19
FI107694B (en) 2001-09-28
AU4270993A (en) 1993-11-29
EP0639364A1 (en) 1995-02-22
FI935972A (en) 1994-02-24
NO934910L (en) 1994-01-26
DE69325801T2 (en) 1999-11-18
GR3031088T3 (en) 1999-12-31
CA2112661C (en) 2002-02-26
PL172973B1 (en) 1997-12-31
JPH0614975A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
WO1993021890A1 (en) Vessel having a plurality of chambers
US5423421A (en) Containers having plurality of chambers
WO1992008434A1 (en) Multi-chamber vessel
JP3419139B2 (en) Flexible multi-chamber container
JP5056754B2 (en) container
JP3060132B2 (en) Double chamber container
JP3060133B2 (en) Double chamber container
JP3700039B2 (en) Plastic film multi-chamber container
JP3707899B2 (en) Multi-chamber container
JP2001252333A (en) Double chamber container for medical treatment
JP3707898B2 (en) Multi-chamber container
JPH1156968A (en) Packaging body for medical container
JP3070596U (en) Double chamber container
JPH1176367A (en) Container for medical treatment
JP2004016539A (en) Multi-chamber container
JP2004016318A (en) Multi-chamber container
JP2000334042A (en) Medical syringe
JPH1156970A (en) Medical container
JPH10167341A (en) Packaging structure for medical container
JPH10236540A (en) Double chamber container
JPH10218252A (en) Container for storing multi-constituent
JP2004329433A (en) Double chamber container
JPH08215285A (en) Production of double-chamber container
JP2001190639A (en) Medical container
JPH10338275A (en) Packaging member for medical container

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI HU KR NO RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 08170215

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1993911945

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2112661

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 935972

Country of ref document: FI

WWE Wipo information: entry into national phase

Ref document number: 1019940700005

Country of ref document: KR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1993911945

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993911945

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 935972

Country of ref document: FI